Nasdaq Most Active

Form 8.3 – Life Science REIT Plc

March 11, 2026
"BioLife Solutions signs a multi-year agreement with Qkine Limited to distribute cytokine and growth factor products, enhancing its cell and gene therapy portfolio. Learn more about this strategic partnership."

8.3

Share this article: